Company news
Annexin Pharmaceuticals AB news in 2025
Annexin Pharmaceuticals AB's news releases, calls and decks from 2025, newest first.
Annexin advances phase IIa study by initiating patient treatment
December 9, 2025
Annexin gets green light for phase IIa study in diabetic retinopathy
August 13, 2025
Annexin receives approval for Phase 2a study in diabetic retinopathy and RVO
August 7, 2025
Annexin's rights issue 100 percent subscribed, top guarantee commitments included, and resolution on directed issue to guarantors
March 26, 2025
The subscription period in Annexin Pharmaceuticals’ rights issue begins today
March 7, 2025
Annexin Pharmaceuticals publishes Information document in connection with forthcoming rights issue
March 6, 2025